Isolation and Characterization of Circulating Tumor Cells in Patients with Metastatic Colorectal CancerSteven J. Cohen, Neal J. Meropol, Jonathan D. Cheng et al.|Clinical Colorectal Cancer|2006Cited by 189
CAR+ T-Cell Lymphoma Post Ciltacabtagene Autoleucel Therapy for Relapsed Refractory Multiple MyelomaSimon J. Harrison, Piers Blombery, Tamia Nguyen et al.|Blood|2023Cited by 99
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory MyelomaSimon J. Harrison, Piers Blombery, Cyrille Touzeau et al.|New England Journal of Medicine|2025Cited by 58
Biomarker Correlates of Response to Ciltacabtagene Autoleucel in Patients with Relapsed or Refractory Multiple Myeloma from CARTITUDE-1, a Phase 1b/2 Open-Label Study, at the ~3 Year Follow-upRocío Montes de, Enrique Zudaire, Junchen Gu et al.|Blood|2023Cited by 9